FSTX
F-Star Therapeutics Inc
Clinical-stage biopharmaceutical company focused on oncology immunotherapies
CUSIP: 30315R107HealthcareUS1 holder
Total Value
$125.0K
Total Shares
24.4K
Net Share Change
+24.4K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Fairfax Financial Holdings
$125.0K24.4K sharesNEW